 | • レポートコード：MRC2Q12-18972 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、注射用ダカルバジンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 注射用ダカルバジンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 注射用ダカルバジンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 注射用ダカルバジンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの注射用ダカルバジンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の注射用ダカルバジンの売上および2028年までの予測に焦点を当てています。 注射用ダカルバジンのグローバル主要企業には、Shanxi PUDE Pharmaceutical、Guangdong Lingnan Pharmaceutical、Sinopharm A-Think Pharmaceutical、Shandong Ruiying Pioneer Pharmaceutical、Nanjing Pharmaceutical FACTORY、WebMD、Getwell、Sanofi Aventis、Salius、HealthJade、Alkem Laboratories、Wellona Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 注射用ダカルバジン市場は、タイプとアプリケーションによって区分されます。世界の注射用ダカルバジン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 100mg/ボトル（ダカルバジン計算）、200mg/ボトル（ダカルバジン計算） 【アプリケーション別セグメント】 病院薬局、小売薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 注射用ダカルバジン製品概要 - タイプ別市場（100mg/ボトル（ダカルバジン計算）、200mg/ボトル（ダカルバジン計算）） - アプリケーション別市場（病院薬局、小売薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の注射用ダカルバジン販売量予測2017-2028 - 世界の注射用ダカルバジン売上予測2017-2028 - 注射用ダカルバジンの地域別販売量 - 注射用ダカルバジンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別注射用ダカルバジン販売量 - 主要メーカー別注射用ダカルバジン売上 - 主要メーカー別注射用ダカルバジン価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（100mg/ボトル（ダカルバジン計算）、200mg/ボトル（ダカルバジン計算）） - 注射用ダカルバジンのタイプ別販売量 - 注射用ダカルバジンのタイプ別売上 - 注射用ダカルバジンのタイプ別価格 ・アプリケーション別市場規模（病院薬局、小売薬局、その他） - 注射用ダカルバジンのアプリケーション別販売量 - 注射用ダカルバジンのアプリケーション別売上 - 注射用ダカルバジンのアプリケーション別価格 ・北米市場 - 北米の注射用ダカルバジン市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ダカルバジン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの注射用ダカルバジン市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ダカルバジン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の注射用ダカルバジン市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ダカルバジン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の注射用ダカルバジン市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ダカルバジン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの注射用ダカルバジン市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ダカルバジン市場規模（トルコ、サウジアラビア） ・企業情報 Shanxi PUDE Pharmaceutical、Guangdong Lingnan Pharmaceutical、Sinopharm A-Think Pharmaceutical、Shandong Ruiying Pioneer Pharmaceutical、Nanjing Pharmaceutical FACTORY、WebMD、Getwell、Sanofi Aventis、Salius、HealthJade、Alkem Laboratories、Wellona Pharma ・産業チェーン及び販売チャネル分析 - 注射用ダカルバジンの産業チェーン分析 - 注射用ダカルバジンの原材料 - 注射用ダカルバジンの生産プロセス - 注射用ダカルバジンの販売及びマーケティング - 注射用ダカルバジンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 注射用ダカルバジンの産業動向 - 注射用ダカルバジンのマーケットドライバー - 注射用ダカルバジンの課題 - 注射用ダカルバジンの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Dacarbazine for Injection Market
Due to the COVID-19 pandemic, the global Dacarbazine for Injection market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 100mg/Bottle (Calculated As Dacarbazine) accounting for % of the Dacarbazine for Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Dacarbazine for Injection market size is valued at US$ million in 2021, while the US and Europe Dacarbazine for Injection are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Dacarbazine for Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Dacarbazine for Injection include Shanxi PUDE Pharmaceutical, Guangdong Lingnan Pharmaceutical, Sinopharm A-Think Pharmaceutical, Shandong Ruiying Pioneer Pharmaceutical, Nanjing Pharmaceutical FACTORY, WebMD, Getwell, Sanofi Aventis and Salius, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Dacarbazine for Injection Scope and Segment
Dacarbazine for Injection market is segmented by Specification and by Application. Players, stakeholders, and other participants in the global Dacarbazine for Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Specification and by Application for the period 2017-2028.
Segment by Specification
100mg/Bottle (Calculated As Dacarbazine)
200mg/Bottle (Calculated As Dacarbazine)
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Company
Shanxi PUDE Pharmaceutical
Guangdong Lingnan Pharmaceutical
Sinopharm A-Think Pharmaceutical
Shandong Ruiying Pioneer Pharmaceutical
Nanjing Pharmaceutical FACTORY
WebMD
Getwell
Sanofi Aventis
Salius
HealthJade
Alkem Laboratories
Wellona Pharma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Dacarbazine for Injection Product Introduction
1.2 Market by Specification
1.2.1 Global Dacarbazine for Injection Market Size Growth Rate by Specification, 2017 VS 2021 VS 2028
1.2.2 100mg/Bottle (Calculated As Dacarbazine)
1.2.3 200mg/Bottle (Calculated As Dacarbazine)
1.3 Market by Application
1.3.1 Global Dacarbazine for Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dacarbazine for Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Dacarbazine for Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Dacarbazine for Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Dacarbazine for Injection Sales by Region
2.4.1 Global Dacarbazine for Injection Sales by Region (2017-2022)
2.4.2 Global Sales Dacarbazine for Injection by Region (2023-2028)
2.5 Global Dacarbazine for Injection Revenue by Region
2.5.1 Global Dacarbazine for Injection Revenue by Region (2017-2022)
2.5.2 Global Dacarbazine for Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dacarbazine for Injection Sales by Manufacturers
3.1.1 Global Top Dacarbazine for Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Dacarbazine for Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dacarbazine for Injection in 2021
3.2 Global Dacarbazine for Injection Revenue by Manufacturers
3.2.1 Global Dacarbazine for Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Dacarbazine for Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Dacarbazine for Injection Revenue in 2021
3.3 Global Dacarbazine for Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dacarbazine for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dacarbazine for Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Specification
4.1 Global Dacarbazine for Injection Sales by Specification
4.1.1 Global Dacarbazine for Injection Historical Sales by Specification (2017-2022)
4.1.2 Global Dacarbazine for Injection Forecasted Sales by Specification (2023-2028)
4.1.3 Global Dacarbazine for Injection Sales Market Share by Specification (2017-2028)
4.2 Global Dacarbazine for Injection Revenue by Specification
4.2.1 Global Dacarbazine for Injection Historical Revenue by Specification (2017-2022)
4.2.2 Global Dacarbazine for Injection Forecasted Revenue by Specification (2023-2028)
4.2.3 Global Dacarbazine for Injection Revenue Market Share by Specification (2017-2028)
4.3 Global Dacarbazine for Injection Price by Specification
4.3.1 Global Dacarbazine for Injection Price by Specification (2017-2022)
4.3.2 Global Dacarbazine for Injection Price Forecast by Specification (2023-2028)
5 Market Size by Application
5.1 Global Dacarbazine for Injection Sales by Application
5.1.1 Global Dacarbazine for Injection Historical Sales by Application (2017-2022)
5.1.2 Global Dacarbazine for Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Dacarbazine for Injection Sales Market Share by Application (2017-2028)
5.2 Global Dacarbazine for Injection Revenue by Application
5.2.1 Global Dacarbazine for Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Dacarbazine for Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Dacarbazine for Injection Revenue Market Share by Application (2017-2028)
5.3 Global Dacarbazine for Injection Price by Application
5.3.1 Global Dacarbazine for Injection Price by Application (2017-2022)
5.3.2 Global Dacarbazine for Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Dacarbazine for Injection Market Size by Specification
6.1.1 North America Dacarbazine for Injection Sales by Specification (2017-2028)
6.1.2 North America Dacarbazine for Injection Revenue by Specification (2017-2028)
6.2 North America Dacarbazine for Injection Market Size by Application
6.2.1 North America Dacarbazine for Injection Sales by Application (2017-2028)
6.2.2 North America Dacarbazine for Injection Revenue by Application (2017-2028)
6.3 North America Dacarbazine for Injection Market Size by Country
6.3.1 North America Dacarbazine for Injection Sales by Country (2017-2028)
6.3.2 North America Dacarbazine for Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Dacarbazine for Injection Market Size by Specification
7.1.1 Europe Dacarbazine for Injection Sales by Specification (2017-2028)
7.1.2 Europe Dacarbazine for Injection Revenue by Specification (2017-2028)
7.2 Europe Dacarbazine for Injection Market Size by Application
7.2.1 Europe Dacarbazine for Injection Sales by Application (2017-2028)
7.2.2 Europe Dacarbazine for Injection Revenue by Application (2017-2028)
7.3 Europe Dacarbazine for Injection Market Size by Country
7.3.1 Europe Dacarbazine for Injection Sales by Country (2017-2028)
7.3.2 Europe Dacarbazine for Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dacarbazine for Injection Market Size by Specification
8.1.1 Asia Pacific Dacarbazine for Injection Sales by Specification (2017-2028)
8.1.2 Asia Pacific Dacarbazine for Injection Revenue by Specification (2017-2028)
8.2 Asia Pacific Dacarbazine for Injection Market Size by Application
8.2.1 Asia Pacific Dacarbazine for Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Dacarbazine for Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Dacarbazine for Injection Market Size by Region
8.3.1 Asia Pacific Dacarbazine for Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Dacarbazine for Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Dacarbazine for Injection Market Size by Specification
9.1.1 Latin America Dacarbazine for Injection Sales by Specification (2017-2028)
9.1.2 Latin America Dacarbazine for Injection Revenue by Specification (2017-2028)
9.2 Latin America Dacarbazine for Injection Market Size by Application
9.2.1 Latin America Dacarbazine for Injection Sales by Application (2017-2028)
9.2.2 Latin America Dacarbazine for Injection Revenue by Application (2017-2028)
9.3 Latin America Dacarbazine for Injection Market Size by Country
9.3.1 Latin America Dacarbazine for Injection Sales by Country (2017-2028)
9.3.2 Latin America Dacarbazine for Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Dacarbazine for Injection Market Size by Specification
10.1.1 Middle East and Africa Dacarbazine for Injection Sales by Specification (2017-2028)
10.1.2 Middle East and Africa Dacarbazine for Injection Revenue by Specification (2017-2028)
10.2 Middle East and Africa Dacarbazine for Injection Market Size by Application
10.2.1 Middle East and Africa Dacarbazine for Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Dacarbazine for Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Dacarbazine for Injection Market Size by Country
10.3.1 Middle East and Africa Dacarbazine for Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Dacarbazine for Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Shanxi PUDE Pharmaceutical
11.1.1 Shanxi PUDE Pharmaceutical Corporation Information
11.1.2 Shanxi PUDE Pharmaceutical Overview
11.1.3 Shanxi PUDE Pharmaceutical Dacarbazine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Shanxi PUDE Pharmaceutical Dacarbazine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shanxi PUDE Pharmaceutical Recent Developments
11.2 Guangdong Lingnan Pharmaceutical
11.2.1 Guangdong Lingnan Pharmaceutical Corporation Information
11.2.2 Guangdong Lingnan Pharmaceutical Overview
11.2.3 Guangdong Lingnan Pharmaceutical Dacarbazine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Guangdong Lingnan Pharmaceutical Dacarbazine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Guangdong Lingnan Pharmaceutical Recent Developments
11.3 Sinopharm A-Think Pharmaceutical
11.3.1 Sinopharm A-Think Pharmaceutical Corporation Information
11.3.2 Sinopharm A-Think Pharmaceutical Overview
11.3.3 Sinopharm A-Think Pharmaceutical Dacarbazine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sinopharm A-Think Pharmaceutical Dacarbazine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sinopharm A-Think Pharmaceutical Recent Developments
11.4 Shandong Ruiying Pioneer Pharmaceutical
11.4.1 Shandong Ruiying Pioneer Pharmaceutical Corporation Information
11.4.2 Shandong Ruiying Pioneer Pharmaceutical Overview
11.4.3 Shandong Ruiying Pioneer Pharmaceutical Dacarbazine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Shandong Ruiying Pioneer Pharmaceutical Dacarbazine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Shandong Ruiying Pioneer Pharmaceutical Recent Developments
11.5 Nanjing Pharmaceutical FACTORY
11.5.1 Nanjing Pharmaceutical FACTORY Corporation Information
11.5.2 Nanjing Pharmaceutical FACTORY Overview
11.5.3 Nanjing Pharmaceutical FACTORY Dacarbazine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Nanjing Pharmaceutical FACTORY Dacarbazine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Nanjing Pharmaceutical FACTORY Recent Developments
11.6 WebMD
11.6.1 WebMD Corporation Information
11.6.2 WebMD Overview
11.6.3 WebMD Dacarbazine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 WebMD Dacarbazine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 WebMD Recent Developments
11.7 Getwell
11.7.1 Getwell Corporation Information
11.7.2 Getwell Overview
11.7.3 Getwell Dacarbazine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Getwell Dacarbazine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Getwell Recent Developments
11.8 Sanofi Aventis
11.8.1 Sanofi Aventis Corporation Information
11.8.2 Sanofi Aventis Overview
11.8.3 Sanofi Aventis Dacarbazine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Aventis Dacarbazine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Aventis Recent Developments
11.9 Salius
11.9.1 Salius Corporation Information
11.9.2 Salius Overview
11.9.3 Salius Dacarbazine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Salius Dacarbazine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Salius Recent Developments
11.10 HealthJade
11.10.1 HealthJade Corporation Information
11.10.2 HealthJade Overview
11.10.3 HealthJade Dacarbazine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 HealthJade Dacarbazine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 HealthJade Recent Developments
11.11 Alkem Laboratories
11.11.1 Alkem Laboratories Corporation Information
11.11.2 Alkem Laboratories Overview
11.11.3 Alkem Laboratories Dacarbazine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Alkem Laboratories Dacarbazine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Alkem Laboratories Recent Developments
11.12 Wellona Pharma
11.12.1 Wellona Pharma Corporation Information
11.12.2 Wellona Pharma Overview
11.12.3 Wellona Pharma Dacarbazine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Wellona Pharma Dacarbazine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Wellona Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dacarbazine for Injection Industry Chain Analysis
12.2 Dacarbazine for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dacarbazine for Injection Production Mode & Process
12.4 Dacarbazine for Injection Sales and Marketing
12.4.1 Dacarbazine for Injection Sales Channels
12.4.2 Dacarbazine for Injection Distributors
12.5 Dacarbazine for Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dacarbazine for Injection Industry Trends
13.2 Dacarbazine for Injection Market Drivers
13.3 Dacarbazine for Injection Market Challenges
13.4 Dacarbazine for Injection Market Restraints
14 Key Findings in The Global Dacarbazine for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer